Cardiovascular effects of oral pharmacotherapy in erectile dysfunction.
Several drugs have been developed to treat patients with erectile dysfunction (ED). In general, patients prefer orally administered drugs. The use of these drugs (e.g. sildenafil and apomorphine) is reviewed. Because ED is a common problem in men with vascular disease it is important to assess the effect of these drugs on the cardiovascular system. The safe use of these drugs in patients with vascular disease needs to be clearly established in appropriately designed trials.
Vardi
Y
Y
Neurourology Unit, Rambam Medical Center, Haifa, Israel.
Gruenwald
I
I
D001120:Arginine / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D018377:Neurotransmitter Agents / Q000009:adverse effects*; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D010879:Piperazines / Q000009:adverse effects*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
D018377:Neurotransmitter Agents; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D001120:Arginine; D000068677:Sildenafil Citrate